Arcutis initiates pivotal phase III studies of roflumilast cream in patients with atopic dermatitis Jan. 14, 2021
Topline data from pivotal phase II/III VALO study of Qtorin rapamycin in pachyonychia congenita Dec. 24, 2020
Athenex and Almirall’s actinic keratosis treatment receives FDA approval Dec. 15, 2020 By Lee Landenberger Christmas arrived early for Athenex Inc. as the FDA approved Klisyri (tirbanibulin) for treating actinic keratosis on the face or scalp nearly two weeks before the treatment’s PDUFA date.Read More
RSS